Category: Immunotherapy

Merck Ventures creates new immuno-oncology company iOnctura

Merck, a leading science and technology company, today announced its corporate venture arm Merck Ventures created iOnctura SA, Geneva, Switzerland. This immuno-oncology spin-out company was formed around two assets from the Healthcare R&D portfolio of Merck and three assets from Cancer Research Technology (CRT). http://www.worldpharmanews.com/merckgroup/3986-merck-ventures-creates-new-immuno-oncology-company-ionctura